[Althesin in the treatment of status epilepticus]
- PMID: 7453976
[Althesin in the treatment of status epilepticus]
Abstract
In view of its anticonvulsant effects in the experimental animal, its low toxicity, and its manageability, Althesin was used at doses of 80-600 mg in the treatment of barbiturate and benzodiazepine resistant epilepsy in 11 patients aged 15 months to 62 yr. Lasting suspension of the disease was obtained in 8 subjects. Burst suppression was achieved in 7 of these cases with 80-120 drops/min of a 10% solution of Althesin in 10% laevulose. No side-effects were observed.